Glucagon-Like Peptide 1 Fragment 7-37 human
SIGMA/G9416 - ≥96% (HPLC)
Synonym: GLP-1, 7-37; Preproglucagon 78-108
Empirical Formula (Hill Notation): C151H228N40O47
Molecular Weight: 3355.67
MDL Number: MFCD00167940
Linear Formula: C151H228N40O47
Product Type: Chemical
| assay | ≥96% (HPLC) |
| InChI | 1S/C151H228N40O47/c1-17-7 |
| InChI key | GCYXWQUSHADNBF-AAEALURTSA |
| Quality Level | 200 ![]() |
| SMILES string | CC[C@H](C)[C@H](NC(=O)[C@ |
| storage temp. | −20°C |
| UniProt accession no. | P01275 ![]() |
| Amino Acid Sequence: | His-Ala-Glu-Gly-Thr-Phe-T |
| Application: | Glucagon-Like Peptide 1 Fragment 7-37 human has been used: • as a positive control for insulin secretion of pancreatic islets • to test its effect on insulin response in horse islets • in combination with mesenchymal stem cells (MSCs) test its protective effects in myocardial infarction |
| Biochem/physiol Actions: | Glucagon-Like Peptide 1 Fragment 7-37 human (GLP-1-(7-37)) interacts with the GLP-1 receptor (GLP-1r). It mediates insulin release by stimulating the cyclic AMP accumulation in islet cells GLP-l(7-37) is a potential therapeutic agent due to its insulin-secretagogue functionality. |
| General description: | GLP-1 (7-37) is a truncated, bioactive form of GLP-1 that is the product of proglucagon processing in intestinal endocrine L cells. It is a potent insulinotropic hormone. |
| General description: | Glucagon-Like Peptide 1 Fragment 7-37 human (GLP-1-(7-37)) is an amino-truncated form of GLP-1. |
| General description: | Truncated, bioactive form of GLP-1; potent insulinotropic hormone. |
| Other Notes: | Lyophilized from 0.1% TFA in H2O |
| Packaging: | 0.5 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥96% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 51111800 |

